Hrt Financial LP Eloxx Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.0 $90,348 - $148,112	-74,056 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.35 - $3.36 $99,975 - $248,828	74,056 New	74,056 $147,000
Q1 2020 May 15, 2020	SELL	$1.96 - $7.96 $45,499 - $184,783	-23,214 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.19 - $7.56 $74,052 - $175,497	23,214 New	23,214 $170,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.